X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
Details:
POINT is licensing SCK CEN’s n.c.a. Lu-177 purification technology to both further increase the resiliency of POINT’s supply chain, as well as to lower POINT’s cost of medical isotope, the most expensive raw material used in radiopharmaceutical production.
Lead Product(s): PNT2002,Lutetium-177
Therapeutic Area: Oncology Product Name: PNT2001
Highest Development Status: Phase IIIProduct Type: Large molecule
Partner/Sponsor/Collaborator: Belgian Nuclear Research Center
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement November 24, 2021
Details:
Telix has extended its non-exclusive global clinical and commercial supply agreements with Garching-based ITM AG for the supply of highly pure no-carrier-added lutetium-177 , a therapeutic isotope used in Telix’s portfolio of Molecularly Targeted Radiation products.
Lead Product(s): Lutetium-177,Undisclosed
Therapeutic Area: Oncology Product Name: DP-3311
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Telix Pharmaceuticals
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 18, 2021
Details:
Fuding will support SHINE's continued effort to make strong progress in their work to commercialize molybdenum-99, an essential diagnostic isotope, and lutetium-177, a therapeutic isotope that is showing great promise for the treatment of cancer.
Lead Product(s): Lutetium-177
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Fidelity Management and Research Company LLC
Deal Size: $80.0 million Upfront Cash: Undisclosed
Deal Type: Series C Financing September 02, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
